KS

Kalyani Sarang Deshmukh

Active Director Designated Partner DIN 11816078
DIN 11816078 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Kalyani Sarang Deshmukh

Kalyani Sarang Deshmukh is a Designated Partner at Csn Diagnostic Llp (since 2026).

DIN 11816078
Primary Designation Designated Partner
First Appointment 10 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner10 Jul 20262026Active

Board colleagues of Kalyani Sarang Deshmukh

NameDINCompanyDesignation
Dattopant Shivajirao Joshi11816077Csn Diagnostic LlpDesignated Partner
Dhananjay Dhondopant Vadikar10559659Csn Diagnostic LlpDesignated Partner
Vikas Rajabhau Joshi11030655Csn Diagnostic LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Csn Diagnostic Llp
Premium access

Shareholding and investment profile for Kalyani Sarang Deshmukh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kalyani Sarang Deshmukh

Kalyani Sarang Deshmukh currently holds 1 directorship: Csn Diagnostic Llp (Designated Partner, since 10 Jul 2026).

Kalyani Sarang Deshmukh was first appointed on 10 Jul 2026 as Designated Partner at Csn Diagnostic Llp.

The current boards of Kalyani Sarang Deshmukh's companies include Dattopant Shivajirao Joshi (Csn Diagnostic Llp), Dhananjay Dhondopant Vadikar (Csn Diagnostic Llp), Vikas Rajabhau Joshi (Csn Diagnostic Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available